IO Biotech, Inc.IOBTNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank91
3Y CAGR+62.9%
5Y CAGR-7.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+62.9%/yr
Quarterly compound
5Y CAGR
-7.3%/yr
Recent acceleration
Percentile
P91
Near historical high
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 67.50% |
| Q2 2025 | -17.65% |
| Q1 2025 | 29.17% |
| Q4 2024 | -33.33% |
| Q3 2024 | -16.13% |
| Q2 2024 | -3.33% |
| Q1 2024 | 25.00% |
| Q4 2023 | 6.98% |
| Q3 2023 | 41.10% |
| Q2 2023 | -23.73% |
| Q1 2023 | 15.71% |
| Q4 2022 | -29.63% |
| Q3 2022 | 15.62% |
| Q2 2022 | -6.67% |
| Q1 2022 | 27.71% |
| Q4 2021 | -388.24% |
| Q3 2021 | 94.88% |
| Q2 2021 | -937.50% |
| Q1 2021 | -45.45% |
| Q4 2020 | 26.67% |
| Q3 2020 | 98.49% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |